GO
Loading...

Health Care Equipment and Supplies

More

  • May 20- Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. Medtronic said it would give Edwards a one-time payment of $750 million, plus ongoing royalty payments through April 2022, based on a percentage of CoreValve sales.

  • May 20- Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • Boston Scientific gets subpoena over defibrillators Thursday, 8 May 2014 | 11:37 PM ET

    May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.

  • *Sees 2nd- qtr revenue $2.50 bln- $2.53 bln vs est. May 7- Technology outsourcing company Cognizant Technology Solutions Corp said growth in its North America healthcare business would remain slow this quarter due to lower spending by customers adjusting to U.S. healthcare reforms.

  • *Forecasts 2nd- quarter revenue $2.50 bln- $2.53 bln vs est. May 7- Technology outsourcing company Cognizant Technology Solutions Corp said growth in its North America healthcare business would remain slow this quarter due to lower spending by customers as they adjust to changes brought on by Obamacare.

  • WASHINGTON, April 30- The United States has resisted lobbying by U.S. drug and pharmaceutical companies to take tougher trade action against India for its intellectual property policies, deciding against risking ties with a likely new government in New Delhi.

  • April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..

  • UPDATE 1-Zimmer to buy Biomet in $13.35 bln deal Thursday, 24 Apr 2014 | 7:48 AM ET

    April 24- Medical device maker Zimmer Holdings Inc said it would buy orthopedic products company Biomet Inc in a deal valued at about $13.35 billion to broaden its portfolio of products that treat bone and joint-related disorders.

  • Zimmer to buy Biomet in $13.35 bln deal Thursday, 24 Apr 2014 | 7:18 AM ET

    April 24- Medical device maker Zimmer Holdings Inc said it would acquire orthopedic products company Biomet Inc in a deal valued at about $13.35 billion.

  • April 22- Intuitive Surgical Inc on Tuesday lowered its forecast for procedure growth for its da Vinci surgical robots, citing a slowdown in U.S. gynecology procedures. The medical device maker said it now expects da Vinci procedure growth in a range of 2 percent to 8 percent, down from the prior forecast of 9 percent to 12 percent.

  • April 22- The U.S. Food and Drug Administration on Tuesday proposed speeding up medical device approvals for patients who have no other treatment options through a new program focused on earlier and more frequent interactions between companies and FDA staff.

  • The proposed Expedited Access Premarket Approval Application program would feature earlier and more frequent interactions between companies and FDA staff. The program is not a new pathway to market, the FDA said, but rather a change in approach aimed at reducing the time it takes to develop a product and get it to market.

  • April 22- The U.S. Food and Drug Administration proposed on Tuesday a new, more collaborative approach for faster approval of high-risk medical devices intended to treat patients with serious conditions with no other treatment options.

  • *Philips Q1 EBITA 314 mln euros vs Rtrs poll avg 341 mln. *Q1 hit by weaker Russia, China, currency effects. FRANKFURT, April 22- Philips reported a bigger-than-expected fall in quarterly operating profit and warned of a challenging 2014 owing to unfavourable exchange rates and slowing demand for medical equipment in China and Russia.

  • WASHINGTON, April 17- The United States said on Thursday it would send Ukraine's armed forces medical supplies, sleeping mats and other non-lethal aid, seeking to signal support for Kiev while stopping far short of adding any U.S. weaponry to a deepening standoff with Russia.

  • DEFENSE SECRETARY: UNITED STATES HAS APPROVED ADDITIONAL NON-LETHAL SUPPORT TO UKRAINE, INCLUDING MEDICAL SUPPLIES AND SHELTERS.

  • April 15- U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

  • April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.

  • J&J beats forecasts, helped by new medicines Tuesday, 15 Apr 2014 | 10:06 AM ET

    Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.